Skip to content
ClinCalc Pro
Menu
Beta-lactam antibiotic Pregnancy: Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, and limited human data do not indicate an increased risk of congenital malformations; amoxicillin may be used in pregnancy when the potential benefits outweigh the potential risks. Excreted into breast milk in small quantities with a possible risk of sensitisation — diarrhoea and fungal infection of the mucous membranes are possible in the breast-fed infant, so breast-feeding might have to be discontinued; use during breast-feeding only after benefit/risk assessment by the physician in charge.

Amoxicillin (Otitis Media / Sinusitis)

Brand names: Amoxil

Used in: Sepsis Pneumonia COPD Urinary Tract Infection

Amoxicillin is a broad-spectrum penicillin used for respiratory, ENT, urinary and other infections, and within Helicobacter pylori eradication.

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: Adults and children ≥ 40 kg — Acute otitis media: 500 mg every 8 hours, or 750 mg to 1 g every 12 hours. Acute bacterial sinusitis: 250 mg to 500 mg every 8 hours, or 750 mg to 1 g every 12 hours
Route: Oral
Frequency: Every 8 hours, or every 12 hours for the higher unit doses
Source: UK SPC (eMC) for Amoxicillin 250 mg/5 ml Powder for Oral Suspension Sugar Free, §4.2 (https://www.medicines.org.uk/emc/product/14145/smpc). IMPORTANT SOURCE CAVEAT: the §4.2 dose table was flattened into running text during fetch, so indication-to-dose pairing must be confirmed against the SPC table before publication. As fetched, the text reads '…Acute bacterial sinusitis / Asymptomatic bacteriuria in pregnancy — 250 mg to 500 mg every 8 hours or 750 mg to 1 g every 12 hours; Acute pyelonephritis / Dental abscess with spreading cellulitis — for severe infections 750 mg to 1 g every 8 hours; Acute cystitis — may be treated with 3 g twice daily for one day; Acute otitis media — 500 mg every 8 hours, 750 mg to 1 g every 12 hours; Acute streptococcal tonsillitis and pharyngitis / Acute exacerbations of chronic bronchitis — for severe infections 750 mg to 1 g every 8 hours for 10 days'. The dose selected should take account of the expected pathogens and their likely susceptibility, the severity and site of the infection, and the age, weight and renal function of the patient; official treatment guidelines for each indication should be consulted. The duration of therapy should be determined by the type of infection and the response of the patient and should generally be as short as possible. No maximum daily dose is stated in §4.2 for otitis media or sinusitis (maxima of 4 g/day and 6 g/day are stated only for early and late Lyme disease respectively). ELDERLY: no dose adjustment is considered necessary. HEPATIC IMPAIRMENT: dose with caution and monitor hepatic function at regular intervals. METHOD OF ADMINISTRATION: for oral use; absorption is unimpaired by food; therapy can be started parenterally according to the IV formulation's dosing recommendations and continued with an oral preparation. §4.5 (interactions) was NOT present in the fetched bundle — source the interaction section separately.

Paediatric dose

Route: Oral
Frequency: Total daily dose given in divided doses; twice daily dosing regimens should only be considered when the dose is in the upper range
Max: Not stated for these indications in the fetched §4.2 table (children weighing 40 kg or more should be prescribed the adult dosage)
SPC §4.2, children weighing < 40 kg, for acute bacterial sinusitis, acute otitis media, community acquired pneumonia, acute cystitis, acute pyelonephritis and dental abscess with spreading cellulitis: '20 to 90 mg/kg/day in divided doses'. A range is given rather than a single figure, so dosePerKg is left null — use the quoted range. (By contrast the SPC gives 40 to 90 mg/kg/day for acute streptococcal tonsillitis and pharyngitis, and 100 mg/kg/day in three divided doses for typhoid and paratyphoid fever.) Amoxicillin Paediatric Suspension is recommended for children under six months of age. Renal impairment in children < 40 kg: GFR > 30 mL/min no adjustment; GFR 10 to 30 mL/min 15 mg/kg twice daily; GFR < 10 mL/min 15 mg/kg as a single daily dose. Verify all paediatric dosing against a children's formulary.

Dose adjustments

Renal

Adults and children ≥ 40 kg: GFR greater than 30 mL/min — no adjustment necessary; GFR 10 to 30 mL/min — maximum 500 mg twice daily; GFR less than 10 mL/min — maximum 500 mg/day. Haemodialysis (adults and children over 40 kg): 500 mg every 24 h, with one additional 500 mg dose before dialysis and a further 500 mg after dialysis to restore circulating drug levels. Peritoneal dialysis: maximum 500 mg/day. In children < 40 kg parenteral therapy is preferred in the majority of cases (see paedDose notes for the paediatric renal figures).

Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

US labelling (FDA)

Reference — US labelling, may differ from UK

Adults and Pediatric Patients greater than 40 kg: 500 or 875 mg every 12 hours or 250 or 500 mg every 8 hours, based on the amoxicillin component. ( 2.2 , 2.3 ) Pediatric patients aged 12 weeks (3 months) and older: 25 to 45 mg/kg/day every 12 hours or 20 to 40 mg/kg/day every 8 hours, up to the adult dose. ( 2.3 ) Neonates and infants less than 12 weeks of age: 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Use of the 125 mg/5 mL oral suspension is recommended. ( 2.3 ) 2.1 Important Administration Instructions Amoxicillin and Clavulanate Potassium may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when Amoxicillin and …

Source: US FDA prescribing information (openFDA / DailyMed), label dated 2024-04-30. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.

Contraindications

  • Hypersensitivity to the active substance, to any of the penicillins or to any of the excipients
  • History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam)

Side effects

  • Common: diarrhoea and nausea (clinical trial data)
  • Common: skin rash; uncommon urticaria and pruritus
  • Uncommon: vomiting
  • Very rare: severe allergic reactions including angioneurotic oedema, anaphylaxis, serum sickness and hypersensitivity vasculitis; not known — Kounis syndrome
  • Very rare: antibiotic-associated colitis (including pseudomembranous and haemorrhagic colitis); hepatitis and cholestatic jaundice; interstitial nephritis and crystalluria (including acute renal injury)
  • Very rare: severe cutaneous reactions — erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis, AGEP and DRESS; reversible leucopenia, thrombocytopenia and haemolytic anaemia; convulsions

Clinical monograph

How it works

A beta-lactam that inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins.

Prescribing in practice

  • Contraindicated in penicillin allergy; it commonly causes a non-allergic rash in glandular fever, so avoid it empirically there.
  • Many respiratory/ENT infections are viral or self-limiting — prescribe per local guidance and consider delayed prescribing.
  • Reduce the dose in significant renal impairment.

Monitoring

Short courses need no routine monitoring; review response and adverse effects.

Counselling the patient

  • Complete the prescribed course.
  • Report a rash, swelling or difficulty breathing (possible allergy).
  • Report severe or prolonged diarrhoea.

Evidence & guidelines

First-line for many bacterial respiratory/ENT infections per NICE/PHE antimicrobial guidance, within antibiotic-stewardship principles.

Reference: NICE NG98 AOM; PHE AOM Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.